Metabolic Syndrome and Early-Onset Coronary Artery Disease

2001, Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486 Anderson, 2004, Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease?, Cardiology, 101, 185, 10.1159/000076695 Hsia, 2003, Metabolic syndrome and coronary angiographic disease progression: the Women’s Angiographic Vitamin & Estrogen trial, Am Heart J, 146, 439, 10.1016/S0002-8703(03)00227-8 Hunt, 2004, National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study, Circulation, 110, 1251, 10.1161/01.CIR.0000140762.04598.F9 Lakka, 2002, The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men, JAMA, 288, 2709, 10.1001/jama.288.21.2709 Malik, 2005, Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein, Diabetes Care, 28, 690, 10.2337/diacare.28.3.690 McNeill, 2005, The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study, Diabetes Care, 28, 385, 10.2337/diacare.28.2.385 Onat, 2002, Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation, Atherosclerosis, 165, 285, 10.1016/S0021-9150(02)00236-8 Sattar, 2003, Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study, Circulation, 108, 414, 10.1161/01.CIR.0000080897.52664.94 Irace, 2005, Components of the metabolic syndrome and carotid atherosclerosis: role of elevated blood pressure, Hypertension, 45, 597, 10.1161/01.HYP.0000158945.52283.c2 McNeill, 2004, Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (the ARIC study), Am J Cardiol, 94, 1249, 10.1016/j.amjcard.2004.07.107 Reilly, 2004, Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis, Circulation, 110, 803, 10.1161/01.CIR.0000138740.84883.9C Wong, 2003, The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium, J Am Coll Cardiol, 41, 1547, 10.1016/S0735-1097(03)00193-1 de Ferranti, 2004, Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey, Circulation, 110, 2494, 10.1161/01.CIR.0000145117.40114.C7 Grundy, 2005, Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Circulation, 112, 2735, 10.1161/CIRCULATIONAHA.105.169404 Genuth, 2003, Follow-up report on the diagnosis of diabetes mellitus, Diabetes Care, 26, 3160, 10.2337/diacare.26.11.3160 Ford, 2005, Prevalence of insulin resistance and the metabolic syndrome with alternative definitions of impaired fasting glucose, Atherosclerosis, 181, 143, 10.1016/j.atherosclerosis.2005.01.002 Kahn, 2005, The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care, 28, 2289, 10.2337/diacare.28.9.2289 Reaven, 2005, The metabolic syndrome: requiescat in pace, Clin Chem, 51, 931, 10.1373/clinchem.2005.048611 Friedman, 1988, CARDIA: study design, recruitment, and some characteristics of the examined subjects, J Clin Epidemiol, 41, 1105, 10.1016/0895-4356(88)90080-7 Iribarren, 2005, Association of lipoprotein-associated phospholipase A2 mass and activity with calcified coronary plaque in young adults: the CARDIA study, Arterioscler Thromb Vasc Biol, 25, 216, 10.1161/01.ATV.0000148322.89911.44 Alberti, 1998, Definition, diagnosis and classification of diabetes mellitus and its complications, Diabet Med, 15, 539, 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S Alexander, 2003, NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older, Diabetes, 52, 1210, 10.2337/diabetes.52.5.1210 Yarnell, 1998, Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies, Heart, 79, 248, 10.1136/hrt.79.3.248 Turhan, 2005, High prevalence of metabolic syndrome among young women with premature coronary artery disease, Coron Artery Dis, 16, 37, 10.1097/00019501-200502000-00007 Isomaa, 2001, Cardiovascular morbidity and mortality associated with the metabolic syndrome, Diabetes Care, 24, 683, 10.2337/diacare.24.4.683 Orchard, 2005, The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial, Ann Intern Med, 142, 611, 10.7326/0003-4819-142-8-200504190-00009